Abstract
Bentham Science Publishers would like to thank and appreciate the co-operation from all reviewers (Editorial Board & External Reviewers) for their constructive comments and feedback on the manuscripts submitted to Recent Patents on Inflammation & Allergy Drug Discovery. Their efforts have contributed greatly to the high quality and continuous growth of the journal. Given below is the list of reviewers who reviewed articles received for the Journal during 2011-2012:.....
Recent Patents on Inflammation & Allergy Drug Discovery
Title:Acknowledgment to Reviewers
Volume: 6 Issue: 3
Author(s): Bentham Science Publishers
Affiliation:
Abstract: Bentham Science Publishers would like to thank and appreciate the co-operation from all reviewers (Editorial Board & External Reviewers) for their constructive comments and feedback on the manuscripts submitted to Recent Patents on Inflammation & Allergy Drug Discovery. Their efforts have contributed greatly to the high quality and continuous growth of the journal. Given below is the list of reviewers who reviewed articles received for the Journal during 2011-2012:.....
Export Options
About this article
Cite this article as:
Science Publishers Bentham, Acknowledgment to Reviewers, Recent Patents on Inflammation & Allergy Drug Discovery 2012; 6 (3) . https://dx.doi.org/10.2174/187221312802652866
DOI https://dx.doi.org/10.2174/187221312802652866 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice
Current Drug Metabolism Obstructive Sleep Apnea and Autoimmune Rheumatic Disease: Is there Any Link?
Inflammation & Allergy - Drug Targets (Discontinued) A Novel Desensitization Protocol for Infliximab Hypersensitivity in a 13-Year Old Patient with Pustular Psoriasis
Current Drug Safety Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients
Current Neurovascular Research Cellular Senescence in the Development and Treatment of Cancer
Current Pharmaceutical Design NO-NSAIDs: From Inflammatory Mediators to Clinical Readouts
Inflammation & Allergy - Drug Targets (Discontinued) Mass Spectrometric Analysis of F2-Isoprostanes: Markers and Mediators in Human Disease
Current Pharmaceutical Analysis Cellular and Molecular Pathways that Lead to Progression and Regression of Renal Fibrogenesis
Current Molecular Medicine Editorial (Thematic Issue: Natural Products for the Attenuation of Allergic Airway Inflammation)
Current Pharmaceutical Design From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Human Hepatocarcinogenesis
Current Molecular Medicine Editorial [Hot topic: Natural Antioxidants and their Derivatives:Biology and Clinical Application (Guest Editors: Thea Magrone, Yoshio Kumazawa & Emilio Jirillo)]
Current Topics in Medicinal Chemistry Current Developments for the Diagnosis and Treatment of Irritable Bowel Syndrome
Current Pharmaceutical Design Editorial [Hot Topic: Regulation of Pathogenetic Aspects of Allergic Diseases (Guest Editor: Lydie Izakovicova Holla)]
Current Drug Targets - Inflammation & Allergy Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Stem Cell Transplant and Idiotypic Vaccination for B-Cell Malignancies
Current Topics in Medicinal Chemistry Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic Chronic HCV Non-cirrhotic Treatment-Naïve Egyptian Patients Eradicated with Sofosbuvir Plus Daclatasvir
Current Diabetes Reviews Brain-to-Plasma Distribution Ratio of the Biflavone Amentoflavone in the Mouse
Drug Metabolism Letters <i>Trigonella foenum-graecum</i> Seeds Oil Attenuated Inflammation and Angiogenesis in vivo through Down-Regulation of TNF-α
Anti-Cancer Agents in Medicinal Chemistry A Review of the Immunosuppressive Activity of Cyclosporine Metabolites:New Insights into an Old Issue
Current Clinical Pharmacology